Prime Medicine (NASDAQ:PRME) Shares Gap Up - Here's Why

Key Points

• PRME gapped up pre-market — it opened at $3.99 after a $3.83 close, but later traded around $3.73 on a volume of 615,638 shares, indicating intraday volatility.
• Analyst coverage is mixed: Weiss Ratings reaffirmed a Sell while Lifesci Capital gives a Strong Buy, and MarketBeat shows a consensus rating of Moderate Buy.
• Prime Medicine is a biotechnology company developing Prime Editors gene‑editing therapies; the stock has a market cap of $668.94 million, a negative P/E (‑2.75), and a high beta (2.56), signaling risk and unprofitability.

Prime Medicine, Inc. (NASDAQ:PRME - Get Free Report) shares gapped up before the market opened on Thursday . The stock had previously closed at $3.83, but opened at $3.99. Prime Medicine shares last traded at $3.7310, with a volume of 615,638 shares trading hands.

Wall Street Analyst Weigh In

PRME has been the topic of several research reports. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Prime Medicine in a research report on Monday, December 29th. Lifesci Capital raised Prime Medicine to a "strong-buy" rating in a research note on Monday, March 2nd. One analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy".

Prime Medicine Stock Performance

The firm's fifty day simple moving average is $3.86. The firm has a market cap of $668.94 million, a price-to-earnings ratio of -2.75 and a beta of 2.56.

Prime Medicine Company Profile

We are a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, Prime Editors, to address the widest spectrum of diseases by deploying our Prime Editing technology, which we believe is a versatile, precise, efficient and broad gene editing technology. Genetic mutations implicated in disease are diverse and can range from errors of a single base, known as point mutations, to errors that extend beyond a single base, such as insertions, deletions, duplications, or combinations thereof.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.